companies: 6,640     total market cap: $100.86 T
Aurinia Pharmaceuticals Inc.
AUPH

$1.27 B
Marketcap
$8.86
Share price
CA
Country
$0.09
Change (1 day)
$9.74
Year High
$4.71
Year Low
Biotechnology
Categories

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.

marketcap

Stock price history for Aurinia Pharmaceuticals Inc. (AUPH)

Highest end of day price: $33.08 USD on 2021-10-29

Lowest end of day price: $1.74 USD on 2016-01-19

Stock price history of Aurinia Pharmaceuticals Inc. from 2014 to 2024


What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company. In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

Stock prices are delayed, the delay can range from a few minutes to several hours. MarketCap.tools is not a Financial institution.

Contact

For inquiries or if you want to report a problem write to web@marketcap.tools

© 2023 Marketcap.tools